Evidence map›Paper›PMID 25961009›Full record

ArticleBioMed research international2015

Feature Selection Combined with Neural Network Structure Optimization for HIV-1 Protease Cleavage Site Prediction.

Hui Liu, Xiaomiao Shi, Dongmei Guo, Zuowei Zhao, Yimin

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Hui LiuDepartment of Biomedical Engineering, Dalian University of Technology, Dalian 116024, China.ORCID 0000-0002-2594-7386
Xiaomiao ShiDepartment of Biomedical Engineering, Dalian University of Technology, Dalian 116024, China.
Dongmei GuoSecond Affiliated Hospital, Dalian Medical University, Dalian 116027, China.
Zuowei ZhaoSecond Affiliated Hospital, Dalian Medical University, Dalian 116027, China.ORCID 0000-0002-3411-7026
YiminDepartment of Advanced Medicine, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.
Dalian University of Technology · CNDalian Medical University · CNHokkaido University · JPSecond Affiliated Hospital of Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is crucial to understand the specificity of HIV-1 protease for designing HIV-1 protease inhibitors. In this paper, a new feature selection method combined with neural network structure optimization is proposed to analyze the specificity of HIV-1 protease and find the important positions in an octapeptide that determined its cleavability. Two kinds of newly proposed features based on Amino Acid Index database plus traditional orthogonal encoding features are used in this paper, taking both physiochemical and sequence information into consideration. Results of feature selection prove that p2, p1, p1', and p2' are the most important positions. Two feature fusion methods are used in this paper: combination fusion and decision fusion aiming to get comprehensive feature representation and improve prediction performance. Decision fusion of subsets that getting after feature selection obtains excellent prediction performance, which proves feature selection combined with decision fusion is an effective and useful method for the task of HIV-1 protease cleavage site prediction. The results and analysis in this paper can provide useful instruction and help designing HIV-1 protease inhibitor in the future.

Indexed as

AlgorithmsAmino Acid SequenceBinding SitesHIV-1HIV InfectionsHIV ProteaseHumansModels, ChemicalNeural Networks, ComputerProprotein ConvertasesProtease InhibitorsProtein ConformationSerine EndopeptidasesStructure-Activity RelationshipHIV Proteasemembrane-bound transcription factor peptidase, site 1p16 protease, Human immunodeficiency virus 1Proprotein ConvertasesProtease InhibitorsSerine Endopeptidases

Identifiers

PMID25961009
PMCPMC4413510
OpenAlexW1965871233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.